Daniel Grunder
Président chez GoodWind Holding GmbH
Profil
Daniel Grunder is associated with GoodWind Holding GmbH, Welle Holding AG + Co. KG, and TXP Pharma AG (Switzerland) as a Chairman, Director, and Director respectively.
Postes actifs de Daniel Grunder
| Sociétés | Poste | Début |
|---|---|---|
Welle Holding AG + Co. KG
 Welle Holding AG + Co. KG Home FurnishingsConsumer Durables Welle Holding AG + Co. KG manufactures wooden and upholstered furniture. It provides furniture for kitchen, babies, children and teenagers. The company is headquartered in Paderborn, Germany. | Directeur/Membre du Conseil | - |
TXP Pharma AG (Switzerland)
 TXP Pharma AG (Switzerland) Pharmaceuticals: MajorHealth Technology Part of SynAct Pharma AB, TXP Pharma AG (Switzerland) engages in researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases. The company is based in Baar, Switzerland. TXP Pharma AG (Switzerland was acquired by SynAct Pharma AB from GoodWind Holding GmbH on January 16, 2023 for $264.94 million. | Directeur/Membre du Conseil | - |
GoodWind Holding GmbH
 GoodWind Holding GmbH Financial ConglomeratesFinance GoodWind Holding GmbH is a Swiss company that specializes in the acquisition, management, and sale of securities and similar assets. The private company is based in Baar, Switzerland. The company also handle financing and fiduciary transactions. | Président | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Welle Holding AG + Co. KG
Welle Holding AG + Co. KG Home FurnishingsConsumer Durables Welle Holding AG + Co. KG manufactures wooden and upholstered furniture. It provides furniture for kitchen, babies, children and teenagers. The company is headquartered in Paderborn, Germany. | Consumer Durables |
TXP Pharma AG (Switzerland)
TXP Pharma AG (Switzerland) Pharmaceuticals: MajorHealth Technology Part of SynAct Pharma AB, TXP Pharma AG (Switzerland) engages in researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases. The company is based in Baar, Switzerland. TXP Pharma AG (Switzerland was acquired by SynAct Pharma AB from GoodWind Holding GmbH on January 16, 2023 for $264.94 million. | Health Technology |
GoodWind Holding GmbH
GoodWind Holding GmbH Financial ConglomeratesFinance GoodWind Holding GmbH is a Swiss company that specializes in the acquisition, management, and sale of securities and similar assets. The private company is based in Baar, Switzerland. The company also handle financing and fiduciary transactions. | Finance |
